Individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from first-line immunotherapy in NSCLC

Abstract Background Many studies have compared real-world clinical outcomes of immunotherapy in patients with metastatic non-small cell lung cancer (NSCLC) with reported outcomes data from pivotal trials. However, any differences observed could be only limitedly explored further for causation becaus...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	R. K. Ismail, F. M. N. H. Schramel, M. van Dartel, A. M. G. Pasmooij, C. M. Cramer-van der Welle, D. L. Hilarius, A. de Boer, M. W. J. M. Wouters, E. M. W. van de Garde
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	BMC 2023-01-01
Cyfres:	BMC Medical Research Methodology
Pynciau:	NSCLC Nivolumab Real-world Efficacy- effectiveness gap
Mynediad Ar-lein:	https://doi.org/10.1186/s12874-022-01760-0
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!